The United States Cutaneous Radiation Injury Drug Market is supported by increasing investments in radiation emergency preparedness, medical countermeasures, and advanced wound care research. The country’s focus on developing therapies for radiation-related injuries is encouraging pharmaceutical and biotechnology companies to investigate innovative treatments that can reduce tissue damage...